Cell-mediated immunity in cervical cancer evolution

Electromagnetic Biology and Medicine

Volumn 28, Issue 1, 2009, Pages 1-14

  Jandova A ^a   Pokorny J ^a   Kobilkova J ^b   Janousek M ^b   Masata, J ^b   Trojan, S ^b   Nedbalova M ^b   Dohnalova A ^b   Bekova A ^b   Slavik V ^b   Cocek A ^b   Sanitrak J ^c  

^a INSTITUTE OF PHOTONICS AND ELECTRONICS   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c Senior Consultant   (Czech Republic)

Author keywords

Cell mediated immunity; Cervical cancer evolution; Cervical precancerous lesions; Leukocyte adherence inhibition assay; Warburg effect, High pressure gel chromatography

Indexed keywords

CANCER CELLS; CANCER PATIENTS; CERVICAL CANCER EVOLUTION; CERVICAL CANCERS; CERVICAL CARCINOMA; CERVICAL INTRAEPITHELIAL NEOPLASIAS; CERVICAL LESIONS; CERVICAL PRECANCEROUS LESIONS; LEUKOCYTE ADHERENCE INHIBITION ASSAY; MITOCHONDRIAL ACTIVITY; T LYMPHOCYTES; VIRUS INFECTION; WARBURG EFFECT, HIGH-PRESSURE GEL CHROMATOGRAPHY;

CELL MEMBRANES; CHROMATOGRAPHIC ANALYSIS; CHROMATOGRAPHY; GELATION; GELS; PRESSURE EFFECTS;

ANTIGENS;

MUS;

LACTATE DEHYDROGENASE; TUMOR ANTIGEN;

ARTICLE; CELL ADHESION; CELLULAR IMMUNITY; CYTOLOGY; FEMALE; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOLOGY; LACTIC DEHYDROGENASE TOGAVIRUS; LEUKOCYTE; METABOLISM; MITOCHONDRION; PATHOLOGY; PRECANCER; T LYMPHOCYTE; UTERINE CERVIX TUMOR; VIROLOGY;

ANTIGENS, NEOPLASM; CELL ADHESION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; IMMUNITY, CELLULAR; L-LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE-ELEVATING VIRUS; LEUKOCYTES; MITOCHONDRIA; PRECANCEROUS CONDITIONS; T-LYMPHOCYTES; UTERINE CERVICAL NEOPLASMS;

EID: 67849116829     PISSN: 15368378     EISSN: 15368386     Source Type: Journal    
DOI: 10.1080/15368370802708868     Document Type: Article

References (67)

1. Batyanov, A. P. (1995). Correlation between mitochondria metabolism and the physical characteristics of incubation cells. In: Belousov, L., Popp, F. A., eds. Biophotonics. Non-equilibrium and Coherent Systems in Biology, Biophysics and Biotechnology. Moscow: Bioinform Services Co, pp. 439-446.
2. Bonnet, S., Archer, S. L., et al. (2007). Mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11:37-51.
3. Brandon, M., Baldi, P., Wallace, D. C. (2006). Mitochondrial mutations in cancer. Oncogene 25:4547-4662.
4. Bungener, L., de Mare, A., et al. (2006). A virosomal immunization strategy against cervical cancer and pre-malignant cervical disease. Antivir. Ther. 11:717-727.
5. Burger, D. R. (1979). Leukocyte adherence inhibition. In: Herberman, R. B., McIntire, K. R., eds. Immunodiagnosis of Cancer. New York: Dekker, pp. 1124-1145.
6. Cafruny, W. A., Jones, Q. A., et al. (2003). Glucocorticoid regulation of lactate dehydrogenase-elevating virus replication in macrophages. Virus Res. 92:83-87.
7. Carew, J. S., Huang, P. (2002). Mitochondrial defects in cancer. Mol. Cancer 1:9-20.
8. Chatterjee, A., Mambo, E., Sidransky, D. (2006). Mitochondrial DNA mutations in human cancer. Oncogene 25:4663-4674.
9. Claesson, P. M. (1994). The surface force technique: Interactions between surfactant bilayers and between protein layers. In: Bongrand, P., Claesson, P. M., Curtis, A. S. G., eds. Studying Cell Adhesion. Berlin, Heidelberg: Springer, pp. 15-35.
10. Cross, S. E., Jin, Yu.-S., et al. (2007). Nanomechanical analysis of cells from cancer patients. Nature Nanotechnol. 2:780-783.
11. Cuezva, J. M., Krajewska, M., et al. (2002). The bioenergetic signature of cancer: A marker of tumor progression. Cancer Res. 2:6674-6681.
12. Curtis, A. S. G. (1964). The mechanism of adhesion of cells to glass. J. Cell. Biol. 20:199-215.
13. Curtis, A. S. G. (1973). Cell adhesion. In: Butler, T. A. V., Noble, D., eds. Prog. Biophys. Mol. Biol., vol. 27. Oxford: Pergamon, pp. 317-386.
14. Das, S., Karim, S., et al. (2007). Peripheral blood lymphocyte subpopulations in patients with cervical cancer. Int. J. Gynaecol. Obstet. 98:143-146. Epub June 18, 2007.
15. Ferenczy, A., Coutlée, F., et al. (2003). Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: A review of recent developments. CMAJ 169:431-434.
16. Gipson, T. G., Martin, W. J. (1978). In vivo anti-tumor immunity detected by leukocyte adherence inhibition. Cancer Immunol. Immunother. 3:201-205.
17. Grinnell, F. (1978). Cellular adhesiveness and extracellular substrata. In: Bourne, G. H., Danielli, J. F., eds. International Review of Cytology, vol. 53. New York: Academic Press, pp. 65-144.
18. Grosser, N., Thomson, D. M. P. (1975). Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes. Cancer Res. 35:2571-2579.
19. Guck, J., Erickson, H., et al. (2005). Optical deformability as an inherent cell marker for testing malignant transformation and metastatic competence. Biophys. J. 88:3689-3698.
20. Halliday, W. J., Miller, S. (1972). Leukocyte adherence inhibition: A simple test for cell-mediated immunity and serum block factors. Int. J. Cancer 9:477-483.
21. Hellstroem, I., Hellstroem, K. E., Shantz, G. (1976). Demonstration of tumor-associated immunity with a leukocyte adherence inhibition (LAI) assay. Int. J. Cancer 18:354-361.
22. Holáň, V., Hašek, M., et al. (1974). Antigen mediated macrophage adherence inhibition. Cell. Immunol. 13:107-116.
23. Isakov, N., Feldman, M., Segal, S. (1982). Acute infection of mice with lactic dehydrogenase virus (LDV) impairs the antigen-presenting capacity of their macrophages. Cell. Immunol. 66:317-332.
24. Jandová, A., Čoupek, J., et al. (1984). Preparation of immunologically functional fractions from serum of inbred mice of strain C3H infected with the LDH virus. CS Patent PV 452-84, January 19.
25. Jandová, A., Hurych, J., et al. (1999). Effects of sinusoidal magnetic field on adherence inhibition of leukocytes: Preliminary results. Bioelectrochem. Bioenerg. 48:317-319.
26. Jandová, A., Hurych, J., et al. (2001). Effects of sinusoidal magnetic field on adherence inhibition of leukocytes. Electro- Magnetobiol. 20:397-413.
27. Jandová, A., Kobilková, J., et al. (1996). Study of interaction forces in human CD4Ly. Bioelectrochem. Bioenerg. 41:181-185.
28. Jandová, A., Mhamdi, L., et al. (2005). Effects of magnetic field 0.1 and 0.05mT on leukocyte adherence inhibition. Electromag. Biol. Med. 24:283-292.
29. Jandová, A., Motyčka, K., et al. (1979). "Disease" of the cellular energy system. Sbornik lékařský 81:321-327 (in Czech).
30. Jandová, A., Pokorný, J., et al. (2004). Effects of sinusoidal magnetic field 0.5mT on leukocyte adherence inhibition. Electromag. Biol. Med. 23:81-96.
31. Jandová, A., Sanitrák, J., et al. (1978). Isolation of immunoreactive components from experimental and human tumor tissues and serums by high-performance gel chromatography. J. Chromatogr. 146:253-260.
32. Kaufmann, A. M., Gissmann, L., et al. (1996). Expression of CD80 enhances immunogenicity of cervical carcinoma cells in vitro. Cell. Immun. 169:246-251.
33. King, A., Selak, M. A., Gottlieb, E. (2006). Succinate dehydrogenase and fumarate hydratase: Linking mitochondrial dysfunction and cancer. Oncogene 25:4675-4682.
34. Koppi, T. A., Maluish, A. E., Halliday, W. J. (1979). The cellular mechanism of leukocyte adherence inhibition. J. Immunol. 123:2255-2260.
35. Koss, L. G. (1997). Precancerous lesions of the epithelia of the uterine cervix. In: Wied, G. L., Bibbo, M., et al., eds. Compendium on Diagnostic Cytology, 8th ed. Chicago, pp. 86-94.
36. Kroemer, G. (2006). Mitochondria in cancer. Oncogene 25:4630-4632.
37. Leclercq, G., Willems, J., et al. (1978). Cellular immunity changes caused by LDH virus: Analogy with observations on neuroblastoma-bearing mice. Int. J. Cancer 40:669-675.
38. Lee, B. N., Follen, M., et al. (2006). Deficiencies in myeloid antigen-presenting cells in women with cervical squamous intraepithelial lesions. Cancer 107:999-1007.
39. Lill, R., Mühlenhoff, U. (2005). Iron-sulfur-protein biogenesis in eukaryotes. Trends Biochem. Sci. 30:133-141.
40. Maroudas, N. G. (1975). Adhesion and spreading of cells on charged surfaces. J. Theor. Biol. 49:417-424.
41. Maroudas, N. G. (1977). Sulphonated polystyrene as an optimal substratum for the adhesion and spreading of mesenchymal cells in monovalent and divalent solutions. J. Cell. Physiol. 90:511-519.
42. Marti, J. H., Thomson, D. M. P. (1976). Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition. Brit. J. Cancer 34:116-133.
43. Mathupala, S. P., Ko, Y. H., Pedersen, P. L. (2006). Hexokinase II: Cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene 25:4777-4786.
44. Michaelides, M. C., Simms, E. S. (1980). Immune responses in mice infected with lactic dehydrogenase virus. III. Antibody response to a T-dependent and a T-independent antigen during acute and chronic LDV infection. Cell. Immunol. 50:253-260.
45. Noonan, F. P., Halliday, W. J., et al. (1977). Cell-mediated immunity and serum blocking factors in cancer patients during chemotherapy and immunotherapy. Cancer Res. 37:2473-2480.
46. Passmore, J. A., Milner, M., et al. (2006). Comparison of cervical and blood T-cell responses to human papillomavirus-16 in women with human papillomavirus-associated cervical intraepithelial neoplasia. Immunology 119:507-514. Epub October 9, 2006.
47. Pokorný, J., Jandová, A., et al. (1996). Leukocytes of cancer patients give evidence of fundamental physical forces: A pathway for a new view. Laser Technol. 6:15-23.
48. Riley, V., Wroblewski, F. (1960). Serial lactic dehydrogenase activity in plasma of mice with growing or regressing tumors. Science 132/3420:151-152.
49. Ristow, M., Pfister, M. F., et al. (2000). Frataxin activates mitochondrial energy conversion and oxidative phosphorylation. Proc. Natl. Acad. Sci. USA 97:12239-12243.
50. Roberts, S., Ashmole, I., et al. (1993). Cutaneous and mucosal human papillomavirus E4 proteins form intermediate filament-like structures in epithelial cells. Virology 197:176-187.
51. Rossignol, R., Gilkerson, R., et al. (2004). Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res. 64:985-993.
52. Rowson, K. E. K., Mahy, B. W. J. (1975). Lactic Dehydrogenase Virus. Wien-New York: Springer.
53. Sarkar, A. K., Tortolero-Luna, G., et al. (2005). Inverse correlation of cellular immune responses specific to synthetic peptides from the E6 and E7 oncoproteins of HPV-16 with recurrence of cervical intraepithelial neoplasia in a cross-sectional study. Gynecol. Oncol. 1(99 Suppl.):S251-S261.
54. Schulz, T. J., Thierbach, R., et al. (2006). Induction of oxidative mechanism by mitochondrial frataxin inhibits cancer growth. J. Biol. Chem. 281:977-981.
55. Shani, A., Ritts, R. E., et al. (1978). A prospective evaluation of the leukocyte adherence inhibition test in colorectal cancer and its correlation with carcinoembryonic antigen levels. Int. J. Cancer 22:113-119.
56. Solomon, D., Schiffman., M., Tarone, R. (2001). Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. J. Natl. Cancer Inst. 93:293-299.
57. Suresh, S., Spatz, J., et al. (2005). Connections between single-cell biomechanics and human disease states: Gastrointestinal cancer and malaria. Acta Biomater. 1:15-30.
58. Suresh, S. (2007). Biomechanics and biophysics of cancer cells. Acta Matl. 55:3989-4014.
59. Tataryn, D. N., Macfarlane, J. K., Thomson, D. M. P. (1978). Leukocyte adherence Inhibition for detecting specific tumour immunity in early pancreatic cancer. Lancet 311/8072:1020-1022.
60. Thomson, D. M. P., Tataryn, D. A., et al. (1979). Abrogation of the phenomenon of leukocyte adherence inhibition by excess circulating tumour antigen. Eur. J. Cancer 15:1095-1106.
61. Tlaskalová-Hogenová, H., Čoupek, J., et al. (1980). Affinity chromatography of human lymphocytes on Spheron immunoadsorbent columns. J. Polymer Sci.: Polymer Symp. 68:89-95.
62. Tyner, K. M., Kopelman, R., Philbert, M. A. (2007). "Nanosized voltmeter" enables cellular-wide electric field mapping. Biophys. J. 93:1163-1174.
63. Van Poelgeest, M. I., Nijhuis, E. R., et al. (2003). Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: A review of recent developments. CMAJ 169:431-434.
64. Van Poelgeest, M. I., Nijhuis, E. R., et al. (2006). Distinct regulation and impact of type 1 T-cell immunity against HPV16 L1, E2 and E6 antigens during HPV16-induced cervical infection and neoplasia. Int. J. Cancer 118:675-683.
65. Warburg, O. (1956). On the origin of cancer cells. Science 123/3191:309-314.
66. Warburg, O., Posener, K., Negelein, E. (1924). Über den stoffwechsel der carcinomzelle. Biochem. Z. 152:309-344 (in German).
67. Witkowski, J. A., Brighton, W. D. (1972). Influence of serum on attachment of tissue cells to glass surfaces. Exp. Cell. Res. 70:41-48.